Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels
- 10 May 2000
- journal article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 7 (6), 574-586
- https://doi.org/10.1038/sj.cdd.4400688
Abstract
Cell death and differentiation is a monthly research journal focused on the exciting field of programmed cell death and apoptosis. It provides a single accessible source of information for both scientists and clinicians, keeping them up-to-date with advances in the field. It encompasses programmed cell death, cell death induced by toxic agents, differentiation and the interrelation of these with cell proliferation.Keywords
This publication has 47 references indexed in Scilit:
- Bad Is a BH3 Domain-Containing Protein That Forms an Inactivating Dimer with Bcl-XLMolecular and Cellular Biology, 1997
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997
- Double identity for proteins of the Bcl-2 familyNature, 1997
- Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria BlockedScience, 1997
- Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XLCell, 1996
- Induction of apoptosis by the Bcl-2 homologue BakNature, 1995
- Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell deathCell, 1995
- Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system.Proceedings of the National Academy of Sciences, 1994
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990